HEADER IMMUNE SYSTEM 09-JUN-99 2MPA TITLE BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS CAVEAT 2MPA CYF P 9 HAS WRONG CHIRALITY AT ATOM C10 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MN12H2 IGG2A-KAPPA, LIGHT CHAIN; COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: FAB FRAGMENT; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: MN12H2 IGG2A-KAPPA,HEAVY CHAIN; COMPND 7 CHAIN: H; COMPND 8 FRAGMENT: FAB FRAGMENT; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: CONJUGATE OF PORA P1.16 PEPTIDE WITH FLUORESCEIN; COMPND 11 CHAIN: P; COMPND 12 FRAGMENT: APEX OF EXTRACELLULAR LOOP 4 (VR2) OF PORA, RESIDUES 180 - COMPND 13 187; COMPND 14 SYNONYM: P1.16, AC-TKDTNNNLC(FLUORESCEIN)-NH2; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE, MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 STRAIN: BALB/C; SOURCE 6 CELL_LINE: MN12H2 MURINE-MURINE HYBRIDOMA; SOURCE 7 CELL: B-LYMPHOCYTE HYBRIDOMA; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 10 ORGANISM_COMMON: MOUSE, MOUSE; SOURCE 11 ORGANISM_TAXID: 10090; SOURCE 12 STRAIN: BALB/C; SOURCE 13 CELL_LINE: MN12H2 MURINE-MURINE HYBRIDOMA; SOURCE 14 CELL: B-LYMPHOCYTE HYBRIDOMA; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 18 ORGANISM_TAXID: 32630; SOURCE 19 OTHER_DETAILS: SEQUENCE FROM NEISSERIA MENINGITIDIS (MENINGOCOCCUS), SOURCE 20 STRAIN: H44/76, VARIANT: P1.16 KEYWDS MURINE IMMUNOGLOBULIN IGG2A KAPPA, BACTERICIDAL ANTIBODY, EPITOPE KEYWDS 2 P1.16 OF PORA FROM NEISSERIA MENINGITIDIS, COMPLEX (IMMUNOGLOBULIN- KEYWDS 3 PEPTIDE), IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.M.H.VAN DEN ELSEN,J.N.HERRON,J.KROON,P.GROS REVDAT 8 15-NOV-23 2MPA 1 ATOM REVDAT 7 30-AUG-23 2MPA 1 REMARK LINK REVDAT 6 31-MAY-17 2MPA 1 COMPND SOURCE DBREF SEQADV REVDAT 5 05-OCT-11 2MPA 1 LINK DBREF REVDAT 4 13-JUL-11 2MPA 1 VERSN REVDAT 3 24-FEB-09 2MPA 1 VERSN REVDAT 2 01-APR-03 2MPA 1 JRNL REVDAT 1 23-JUN-99 2MPA 0 JRNL AUTH J.M.VAN DEN ELSEN,J.N.HERRON,P.HOOGERHOUT,J.T.POOLMAN, JRNL AUTH 2 E.BOEL,T.LOGTENBERG,J.WILTING,D.J.CROMMELIN,J.KROON,P.GROS JRNL TITL BACTERICIDAL ANTIBODY RECOGNITION OF A PORA EPITOPE OF JRNL TITL 2 NEISSERIA MENINGITIDIS: CRYSTAL STRUCTURE OF A FAB FRAGMENT JRNL TITL 3 IN COMPLEX WITH A FLUORESCEIN-CONJUGATED PEPTIDE. JRNL REF PROTEINS V. 29 113 1997 JRNL REFN ISSN 0887-3585 JRNL PMID 9294871 JRNL DOI 10.1002/(SICI)1097-0134(199709)29:1<113::AID-PROT9>3.3.CO;2- JRNL DOI 2 U REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.VAN DEN ELSEN,L.VANDEPUTTE-RUTTEN,J.KROON,P.GROS REMARK 1 TITL BACTERICIDAL ANTIBODY RECOGNITION OF MENINGOCOCCAL PORA BY REMARK 1 TITL 2 INDUCED FIT: COMPARISON OF LIGANDED AND UNLIGANDED FAB REMARK 1 TITL 3 STRUCTURES REMARK 1 REF J.BIOL.CHEM. V. 3 1495 1999 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.274.3.1495 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.3 REMARK 3 NUMBER OF REFLECTIONS : 14183 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.090 REMARK 3 FREE R VALUE TEST SET COUNT : 1397 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.69 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1133 REMARK 3 BIN R VALUE (WORKING SET) : 0.3448 REMARK 3 BIN FREE R VALUE : 0.4043 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 163 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3506 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 51 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.11600 REMARK 3 B22 (A**2) : 9.26400 REMARK 3 B33 (A**2) : -3.14700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -18.40400 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM SIGMAA (A) : 0.46 REMARK 3 LOW RESOLUTION CUTOFF (A) : 20.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.48 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.533 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.49 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.770 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.200 ; 1.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.200 ; 1.500 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.580 ; 1.500 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.580 ; 2.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 64.70 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CAMI.PAR REMARK 3 PARAMETER FILE 3 : NACE.PAR REMARK 3 PARAMETER FILE 4 : SPEP.PAR, FLU.PAR, CD.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CAMI.TOP REMARK 3 TOPOLOGY FILE 3 : NACE.TOP REMARK 3 TOPOLOGY FILE 4 : SPEP.TOP, FLU.TOP, CD.TOP, H20.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MPA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JUN-99. REMARK 100 THE DEPOSITION ID IS D_1000001170. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-95 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR571 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : COLLIMATOR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAC SCIENCE DIP-2020 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15404 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : 0.05400 REMARK 200 FOR THE DATA SET : 16.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.35700 REMARK 200 R SYM FOR SHELL (I) : 0.35700 REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 2HFL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE MN12H2 FAB PEPTIDE COMPLEX WAS REMARK 280 CRYSTALLIZED FROM 15% W/V PEG 20000, 100 MM SODIUM ACETATE, PH REMARK 280 4.6, 20 MM CDCL2, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.55000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 5630 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE H 225 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP L 17 174.44 -58.64 REMARK 500 VAL L 56 -46.13 57.95 REMARK 500 ASP L 87 21.34 -62.63 REMARK 500 SER L 96 26.85 -141.21 REMARK 500 THR L 205 15.07 -58.09 REMARK 500 SER L 206 147.81 -177.09 REMARK 500 VAL H 2 102.86 75.03 REMARK 500 ALA H 16 -166.57 -77.41 REMARK 500 GLN H 43 177.16 -46.29 REMARK 500 SER H 85 74.05 32.20 REMARK 500 ALA H 92 -168.34 -170.46 REMARK 500 TYR H 100 127.84 -174.79 REMARK 500 PHE H 106 68.95 -166.03 REMARK 500 ASP H 109 91.40 -172.97 REMARK 500 CYS H 136 -168.84 63.83 REMARK 500 ASP H 138 150.49 -45.52 REMARK 500 ASN H 163 60.32 36.89 REMARK 500 SER H 180 73.72 46.74 REMARK 500 SER H 193 -6.47 -57.82 REMARK 500 SER H 210 17.45 -148.66 REMARK 500 ASP P 3 -171.66 -59.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 CD: THIS PUTATIVE CADMIUM ION IS ASSIGNED TO A 6 SIGMA REMARK 600 DENSITY PEAK IN A 2|FO|-|FC| MAP; IT IS COORDINATED BY TWO REMARK 600 WATER MOLECULES AND AN IMIDAZOLIUM NITROGEN OF HIS-L98 OF REMARK 600 MN12H2. REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CD L 220 CD REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS L 98 ND1 REMARK 620 2 HOH L 243 O 114.1 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CD L 220 REMARK 999 REMARK 999 SEQUENCE REMARK 999 REFERENCE: THE MN12H2 LIGHT CHAIN AMINO ACID SEQUENCE IS REMARK 999 DEDUCED FROM THE GENBANK U60442 NUCLEOTIDE SEQUENCE OF REMARK 999 THE MN12H2 VARIABLE LIGHT DOMAIN. AMINO ACID SEQUENCES REMARK 999 FOR THE CONSTANT DOMAINS WERE TAKEN FROM IGG2A KAPPA REMARK 999 ANTIBODY 4-4-20 (BEDZYK ET AL. (1989) J.BIOL.CHEM., 265, REMARK 999 P. 18615). DBREF 2MPA L 1 120 PDB 2MPA 2MPA 1 120 DBREF 2MPA L 121 219 UNP P01837 IGKC_MOUSE 8 106 DBREF 2MPA H 1 121 PDB 2MPA 2MPA 1 121 DBREF 2MPA H 122 225 UNP P84751 HVM63_MOUSE 121 224 DBREF 2MPA P 1 9 PDB 2MPA 2MPA 1 9 SEQRES 1 L 219 ASP ILE VAL MET THR GLN THR PRO LEU SER LEU PRO VAL SEQRES 2 L 219 SER LEU GLY ASP LYS ALA SER ILE SER CYS ARG SER SER SEQRES 3 L 219 GLN ALA LEU VAL HIS SER ASN GLY ASN THR TYR LEU HIS SEQRES 4 L 219 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO LYS LEU LEU SEQRES 5 L 219 ILE TYR LYS VAL SER ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 L 219 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 L 219 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL PHE SEQRES 8 L 219 PHE CYS SER GLN SER THR HIS VAL PRO ARG THR PHE GLY SEQRES 9 L 219 GLY GLY THR LYS LEU GLU ILE LYS ARG ALA ASP ALA ALA SEQRES 10 L 219 PRO THR VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU SEQRES 11 L 219 THR SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN SEQRES 12 L 219 PHE TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP SEQRES 13 L 219 GLY SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR SEQRES 14 L 219 ASP GLN ASP SER LYS ASP SER THR TYR SER MET SER SER SEQRES 15 L 219 THR LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SEQRES 16 L 219 SER TYR THR CYS GLU ALA THR HIS LYS THR SER THR SER SEQRES 17 L 219 PRO ILE VAL LYS SER PHE ASN ARG ASN GLU CYS SEQRES 1 H 225 GLU VAL ASN LEU GLN GLN SER GLY THR VAL LEU ALA ARG SEQRES 2 H 225 PRO GLY ALA SER VAL ARG MET SER CYS LYS ALA SER GLY SEQRES 3 H 225 TYR SER PHE THR SER TYR TRP LEU HIS TRP ILE LYS GLN SEQRES 4 H 225 ARG PRO GLY GLN GLY LEU GLU TRP ILE GLY GLY ILE TYR SEQRES 5 H 225 PRO GLY ASN ARG ASP THR ARG TYR THR GLN ARG PHE LYS SEQRES 6 H 225 ASP LYS ALA LYS LEU THR ALA VAL THR SER ALA ASN THR SEQRES 7 H 225 ALA TYR MET GLU LEU SER SER LEU THR ASN GLU ASP SER SEQRES 8 H 225 ALA VAL TYR TYR CYS SER ILE ILE TYR PHE ASP TYR ALA SEQRES 9 H 225 ASP PHE ILE MET ASP TYR TRP GLY GLN GLY THR THR VAL SEQRES 10 H 225 THR VAL SER SER ALA LYS THR THR ALA PRO SER VAL TYR SEQRES 11 H 225 PRO LEU ALA PRO VAL CYS GLY ASP THR THR GLY SER SER SEQRES 12 H 225 VAL THR LEU GLY CYS LEU VAL LYS GLY TYR PHE PRO GLU SEQRES 13 H 225 PRO VAL THR LEU THR TRP ASN SER GLY SER LEU SER SER SEQRES 14 H 225 GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER ASP LEU SEQRES 15 H 225 TYR THR LEU SER SER SER VAL THR VAL THR SER SER THR SEQRES 16 H 225 TRP PRO SER GLN SER ILE THR CYS ASN VAL ALA HIS PRO SEQRES 17 H 225 ALA SER SER THR LYS VAL ASP LYS LYS ILE GLU PRO ARG SEQRES 18 H 225 GLY PRO THR ILE SEQRES 1 P 9 THC LYS ASP THR ASN ASN ASN LEU CYF MODRES 2MPA THC P 1 THR N-METHYLCARBONYLTHREONINE MODRES 2MPA CYF P 9 CYS HET THC P 1 10 HET CYF P 9 36 HET CD L 220 1 HETNAM THC N-METHYLCARBONYLTHREONINE HETNAM CYF 5-[2-(2-AMINO-2-CARBAMOYL-ETHYLSULFANYL)-ACETYLAMINO]- HETNAM 2 CYF 2-(3,6-DIHYDROXY-9,9A-DIHYDRO-3H-XANTHEN-9-YL)-BENZOIC HETNAM 3 CYF ACID HETNAM CD CADMIUM ION FORMUL 3 THC C6 H11 N O4 FORMUL 3 CYF C25 H23 N3 O7 S FORMUL 4 CD CD 2+ FORMUL 5 HOH *51(H2 O) HELIX 1 1 SER L 127 SER L 132 1 6 HELIX 2 2 LYS L 188 GLU L 192 1 5 HELIX 3 3 THR H 195 GLN H 199 1 5 SHEET 1 A 4 MET L 4 THR L 7 0 SHEET 2 A 4 ALA L 19 SER L 25 -1 N ARG L 24 O THR L 5 SHEET 3 A 4 ASP L 75 ILE L 80 -1 N ILE L 80 O ALA L 19 SHEET 4 A 4 PHE L 67 SER L 72 -1 N SER L 72 O ASP L 75 SHEET 1 B 2 SER L 10 SER L 14 0 SHEET 2 B 2 LYS L 108 LYS L 112 1 N LYS L 108 O LEU L 11 SHEET 1 C 3 VAL L 90 GLN L 95 0 SHEET 2 C 3 LEU L 38 GLN L 43 -1 N GLN L 43 O VAL L 90 SHEET 3 C 3 LYS L 50 ILE L 53 -1 N ILE L 53 O TRP L 40 SHEET 1 D 4 THR L 119 PHE L 123 0 SHEET 2 D 4 GLY L 134 ASN L 142 -1 N ASN L 142 O THR L 119 SHEET 3 D 4 SER L 179 THR L 187 -1 N LEU L 186 O ALA L 135 SHEET 4 D 4 VAL L 164 THR L 169 -1 N THR L 169 O SER L 179 SHEET 1 E 3 ILE L 149 LYS L 154 0 SHEET 2 E 3 SER L 196 HIS L 203 -1 N THR L 202 O ASN L 150 SHEET 3 E 3 ILE L 210 ASN L 215 -1 N PHE L 214 O TYR L 197 SHEET 1 F 4 ASN H 3 GLN H 6 0 SHEET 2 F 4 VAL H 18 SER H 25 -1 N SER H 25 O ASN H 3 SHEET 3 F 4 THR H 78 LEU H 83 -1 N LEU H 83 O VAL H 18 SHEET 4 F 4 ALA H 68 VAL H 73 -1 N VAL H 73 O THR H 78 SHEET 1 G 2 VAL H 10 ALA H 12 0 SHEET 2 G 2 VAL H 117 VAL H 119 1 N THR H 118 O VAL H 10 SHEET 1 H 5 MET H 108 TRP H 111 0 SHEET 2 H 5 VAL H 93 TYR H 100 -1 N TYR H 100 O MET H 108 SHEET 3 H 5 TRP H 33 GLN H 39 -1 N GLN H 39 O VAL H 93 SHEET 4 H 5 LEU H 45 TYR H 52 -1 N ILE H 51 O LEU H 34 SHEET 5 H 5 ASP H 57 TYR H 60 -1 N ARG H 59 O GLY H 50 SHEET 1 I 4 SER H 128 LEU H 132 0 SHEET 2 I 4 SER H 143 TYR H 153 -1 N LYS H 151 O SER H 128 SHEET 3 I 4 TYR H 183 THR H 192 -1 N VAL H 191 O VAL H 144 SHEET 4 I 4 VAL H 171 PHE H 174 -1 N PHE H 174 O SER H 186 SHEET 1 J 3 THR H 159 TRP H 162 0 SHEET 2 J 3 THR H 202 HIS H 207 -1 N ALA H 206 O THR H 159 SHEET 3 J 3 THR H 212 LYS H 217 -1 N LYS H 216 O CYS H 203 SSBOND 1 CYS L 23 CYS L 93 1555 1555 2.02 SSBOND 2 CYS L 139 CYS L 199 1555 1555 2.04 SSBOND 3 CYS L 219 CYS H 136 1555 1555 2.02 SSBOND 4 CYS H 22 CYS H 96 1555 1555 2.02 SSBOND 5 CYS H 148 CYS H 203 1555 1555 2.03 LINK C THC P 1 N LYS P 2 1555 1555 1.33 LINK C LEU P 8 N CYF P 9 1555 1555 1.33 LINK ND1 HIS L 98 CD CD L 220 1555 1555 2.74 LINK CD CD L 220 O HOH L 243 1555 1555 2.23 CISPEP 1 THR L 7 PRO L 8 0 -0.13 CISPEP 2 VAL L 99 PRO L 100 0 0.23 CISPEP 3 TYR L 145 PRO L 146 0 -0.34 CISPEP 4 PHE H 154 PRO H 155 0 -0.59 CISPEP 5 GLU H 156 PRO H 157 0 0.22 CISPEP 6 TRP H 196 PRO H 197 0 -0.35 SITE 1 AC1 2 HIS L 98 HOH L 243 CRYST1 55.680 69.100 72.950 90.00 112.01 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017960 0.000000 0.007260 0.00000 SCALE2 0.000000 0.014472 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014786 0.00000